Life sciences software & AI news

Showing 1000+ results

Sep 16, 2026

Ayble Health Raises $16M Series A to Expand the Nation's Most Clinically Validated Virtual Digestive Health Clinic

Led by Neon, the oversubscribed-round accelerates expansion into AI precision digestive healthcare and autoimmune health, driven by rapid scaling across national health plans, jumbo employers and major benefit platforms.BOSTON, Sept. 16, 2026 /PRNewswire/ -- Ayble Health, the nation's leading AI-enabled virtual multidisciplinary GI clinic, today announced the close of a $16 million oversubscribed Series A round led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland

Sep 16, 2026

Press release

O'Shaughnessy Ventures Backs Researcher Teaching Machines to Smell

Alistair Pernigo receives an O'Shaughnessy Fellowship to research how machines can identify the chemicals in the air around themGREENWICH, Conn., Sept. 16, 2026 /PRNewswire/ -- O'Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded an O'Shaughnessy Fellowship to Alistair Pernigo, a researcher and entrepreneur based in San Francisco, California.Continue Reading Pernigo will use the fellowship to research how machines can detect and interpret the

Sep 16, 2026

Press release

PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor

Pharmaceutical R&D and Life Sciences Veterans Will Advise PhaseV as it Scales AI Platform to Bridge the Gap Between Clinical Development Strategy, Execution and Regulatory SubmissionBOSTON, Sept. 16, 2026 /PRNewswire/ -- PhaseV, a leader in machine learning for clinical development, today announced the appointment of Klaus Beck, MD, PhD, PhD, former Chief Medical Officer of Organon, and Avi Kulkarni, PhD, MBA, CEO of InoRx, to its Scientific Advisory Board.Dr. Beck and Dr. Kulkarni bring dec

A minimalist illustration of a pill and molecular structure in a dark palette.

Sep 16, 2026

TikTok parent ByteDance raises cash for drug AI spinout Anew

ByteDance has successfully raised $290 million for its AI-driven drug discovery venture, Anew Labs, marking a significant step in the intersection of technology and pharmaceuticals.The funding round was led by prominent investors including HSG, IDG Capital, and Hillhouse Investment, with participation from 5Y Capital. ByteDance maintains a 56% ownership stake in Anew Labs, which was officially spun out as a separate entity in June after being established in 2021. Under the leadership of Liu Kai,

Sep 16, 2026

Press release

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation

September 16, 2026 SYMPHONY receives ITEA’s highest excellence award for connected healthcare ecosystemsAI FORSchung is recognized for innovation in AI-powered fiber-optic sensing Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that two Philips-led public-private research collaborations have received ITEA Awards of Excellence 2026 for advancing AI-enabled innovation in healthcare. SYMPHONY received the ITEA Award of Excelle

Sep 16, 2026

Press release

Novo and Anthropic will collaborate to advance drug discovery with Claude

Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science to advance scientific reasoning for Research and Development (R&D) and agentic software engineeringThis will further build on Novo’s work to become the world’s most AI-driven healthcare company Bagsværd, Denmark, 16 September 2026 – Novo Nordisk and Anthropic today announced a collaboration that will help Novo accelerate the development of new medicines and advanc

Sep 16, 2026

Press release

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

New digital technologies, including Synchrony and SynX, will be featured at HRXStereotaxis CEO to join main-stage panel on Autonomous EP Systems ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its portfolio of digital and robotic technologies will be featured at Heart Rhythm Society’s HRX conference, taking place September 18-20, 2026, in Atlanta, Geor

A vial of drug compound on a lab bench with chemical reagents in the background.

Sep 16, 2026

AI spots drugs that may be repurposed for priority pathogen

Recent advancements in AI have enabled researchers to identify potential drug candidates that could combat resistant infections caused by Streptococcus pneumoniae, a significant public health threat.Led by Pedro Ballester from Imperial College London, the research team utilized three AI algorithms to analyze nearly 7,000 approved and investigational drugs. These algorithms were trained on existing data regarding drug efficacy against resistant bacteria, resulting in the identification of 11 prom

Sep 16, 2026

Press release

MRO Expands Enterprise Clinical Data Management Platform with Acquisition of Vyne Medical

Combination adds new intelligent clinical data intake capabilities to MRO's integrated platform for healthcare organizationsNORRISTOWN, Pa., Sept. 16, 2026 /PRNewswire/ -- MRO, the leading clinical data management platform, announces the acquisition of Vyne Medical, a provider of data intake and intelligent document processing solutions for over 800 hospitals nationwide. Vyne specializes in transforming unstructured information from paper, voice, fax, and images into discrete, digital and intell

A flat illustration of a bacterium symbolizing the vaginal microbiome in a minimalist style.

Sep 16, 2026

Evvy secures $40m to validate AI-based women’s health diagnostics

Evvy has successfully raised $40 million in a Series B funding round aimed at enhancing its AI-driven diagnostic tools for women's health.The funding round, which exceeded expectations, was spearheaded by Catalio Capital Management, with contributions from Rethink Impact, Muse Capital, Alumni Ventures, and several existing investors. Established in 2021 by Priyanka Jain, Laine Bruzek, and Pita Navarro, Evvy specializes in creating a clinical-grade dataset that focuses on the vaginal microbiome a

Sep 16, 2026

Press release

UpRight Science Brings Together Expert Advisory Board to Advance Balance as an Essential Health Measure

Multidisciplinary group brings expertise across medicine, neuroscience, healthcare technology, business, and communications to support the company's mission to make balance easier to measure and track.WEST PALM BEACH, Fla., Sept. 16, 2026 /PRNewswire/ -- With Falls Prevention Awareness Week approaching Sept. 21–25, UpRight Science today announced the advisory board supporting its work to establish balance as an essential measure of health and expand the usage of its FDA-cleared balance software.

Sep 16, 2026

Press release

Nona Biosciences Successfully Develops World's First Language Model Trained on Fully Human Heavy-Chain-Only Antibodies

CAMBRIDGE, Mass., Sept. 16, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced the development of HCAbLM, the world's first language model specifically trained on fully human heavy-chain-only antibodies (HCAbs). HCAbLM was built on a large-scale repertoire comprising 31.8 million fully human HCAb sequences from 73 independently immunized HCAb transgenic mice. The stu

Back to start
Previous
Page 8 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal